Immunogenicity 7393

summary
Sample ID
4007
Response
Negative
Tumor Type
Colon cancer
Gene Symbol
SLITRK1
Transcript ID
NM_001281503
HLA INFO
A*03:01
TCR INFO

No TCR info found!

T cell Tumor cell A*03:01
sequence
Full length protein sequence (696 aa)
MLLWI
1
LLLET
6
SLCFA
11
AGNVT
16
GDVCK
21
EKICS
26
CNEIE
31
GDLHV
36
DCEKK
41
GFTSL
46
QRFTA
51
PTSQF
56
YHLFL
61
HGNSL
66
TRLFP
71
NEFAN
76
FYNAV
81
SLHME
86
NNGLH
91
EIVPG
96
AFLGL
101
QLVKR
106
LHINN
111
NKIKS
116
FRKQT
121
FLGLD
126
DLEYL
131
QADFN
136
LLRDI
141
DPGAF
146
QDLNK
151
LEVLI
156
LNDNL
161
ISTLP
166
ANVFQ
171
YVPIT
176
HLDLR
181
GNRLK
186
TLPYE
191
EVLEQ
196
IPGIA
201
EILLE
206
DNPWD
211
CTCDL
216
LSLKE
221
WLENI
226
PKNAL
231
IGRVV
236
CEAPT
241
RLQGK
246
DLNET
251
TEQDL
256
CPLKN
261
RVDSS
266
LPAPP
271
AQEET
276
FAPGP
281
LPTPF
286
KTNGQ
291
EDHAT
296
PGSAP
301
NGGTK
306
IPGNW
311
QIKIR
316
PTAAI
321
ATGSS
326
RNKPL
331
ANSLP
336
CPGGC
341
SCDHI
346
PGSGL
351
KMNCN
356
NRNVS
361
SLADL
366
KPKLS
371
NVQEL
376
FLRDN
381
KIHSI
386
RKSHF
391
VDYKN
396
LILLD
401
LGNNN
406
IATVE
411
NNTFK
416
NLLDL
421
RWLYM
426
DSNYL
431
DTLSR
436
EKFAG
441
LQNLE
446
YLNVE
451
YNAIQ
456
LILPG
461
TFNAM
466
PKLRI
471
LILNN
476
NLLRS
481
LPVDV
486
FAGVS
491
LSKLS
496
LHNNY
501
FMYLP
506
VAGVL
511
DQLTS
516
IIQID
521
LHGNP
526
WECSC
531
TIVPF
536
KQWAE
541
RLGSE
546
VLMSD
551
LKCET
556
PVNFF
561
RKDFM
566
LLSND
571
EICPQ
576
LYARI
581
SPTLT
586
SHSKN
591
STGLA
596
ETGTH
601
SNSYL
606
DTSRV
611
SISVL
616
VPGLL
621
LVFVT
626
SAFTV
631
VGMLV
636
FILRN
641
RKRSK
646
RRDAN
651
SSASE
656
INSLQ
661
TVCDS
666
SYWHN
671
GPYNA
676
DGAHR
681
VYDCG
686
SHSLS
691
D
696
Mutation Information
DNA mutation:
None
Peptide Range:
634 ~ 658
Mut AA position:
646 (13 in Wild Type peptide)
Alignment
Wild Type:
"TVVGMLVFILRNRKRSKRRDANSSA
||||||||||||.||||||||||||
Mutant:
TVVGMLVFILRNQKRSKRRDANSSA"
reference

Science, 2015

Immunogenicity of somatic mutations in human gastrointestinal cancers

Gene Name (from Reference) SLITRK1

clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

TILs

APC Type

autologous DCs

Assay

IFNg ELISPOT assay